LRRK2 Gly2385Arg polymorphism, cigarette smoking, and risk of sporadic Parkinson's disease: A case-control study in Japan

Journal of the Neurological Sciences

Volumn 297, Issue 1-2, 2010, Pages 15-18

  Miyake, Yoshihiro ^a   Tsuboi, Yoshio ^a   Koyanagi, Midori ^a   Fujimoto, Takahiro ^a   Shirasawa, Senji ^a   Kiyohara, Chikako ^b   Tanaka, Keiko ^a   Fukushima, Wakaba ^c   Sasaki, Satoshi ^d   Yamada, Tatsuo ^a   Oeda, Tomoko ^e   Miki, Takami ^c   Kawamura, Nobutoshi ^b   Sakae, Nobutaka ^b   Fukuyama, Hidenao ^f   Hirota, Yoshio ^c   Nagai, Masaki ^g  

^a FUKUOKA UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

^e UTANO NATIONAL HOSPITAL   (Japan)

^f KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^g SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Case control study; Gly2385Arg; Japan; LRRK2; Parkinson's disease; Smoking

Indexed keywords

LEUCINE RICH REPEAT KINASE 2;

AGED; ARTICLE; CASE CONTROL STUDY; CHINESE; CIGARETTE SMOKING; CONTROLLED STUDY; DEGENERATIVE DISEASE; FEMALE; GENETIC VARIABILITY; GENOTYPE; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; ARGININE; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; GLYCINE; HUMANS; JAPAN; MALE; MIDDLE AGED; PARKINSON DISEASE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN-SERINE-THREONINE KINASES; QUESTIONNAIRES; RETROSPECTIVE STUDIES; RISK FACTORS; SMOKING;

EID: 77956653820     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2010.07.002     Document Type: Article

References (29)

1. M. Funayama, K. Hasegawa, H. Kowa, M. Saito, S. Tsuji, and F. Obata A new locus for Parkinson's disease (PARK8) maps to chromosome 12p11.2-q13.1 Ann Neurol 51 2002 296 301
2. C. Paisán-Ruíz, S. Jain, E.W. Evans, W.P. Gilks, J. Simón, and M. van der Brug et al. Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease Neuron 44 2004 595 600
3. A. Zimprich, S. Biskup, P. Leitner, P. Lichtner, M. Farrer, and S. Lincoln et al. Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology Neuron 44 2004 601 607
4. Y.W. Lu, and E.K. Tan Molecular biology changes associated with LRRK2 mutations in Parkinson's disease J Neurosci Res 86 2008 1895 1901
5. E.K. Tan, H. Shen, L.C. Tan, M. Farrer, K. Yew, and E. Chua et al. The G2019S LRRK2 mutation is uncommon in an Asian cohort of Parkinson's disease patients Neurosci Lett 384 2005 327 329
6. C.S. Lu, E.J. Simons, Y.H. Wu-Chou, A.D. Fonzo, H.C. Chang, and R.S. Chen et al. The LRRK2 I2012T, G2019S, and I2020T mutations are rare in Taiwanese patients with sporadic Parkinson's disease Parkinsonism Relat Disord 11 2005 521 522
7. C.P. Zabetian, M. Yamamoto, A.N. Lopez, H. Ujike, I.F. Mata, and Y. Izumi et al. LRRK2 mutations and risk variants in Japanese patients with Parkinson's disease Mov Disord 24 2009 1034 1041
8. S. Lesage, A. Dürr, M. Tazir, E. Lohmann, A.L. Leutenegger, and S. Janin et al. LRRK2 G2019S as a cause of Parkinson's disease in North African Arabs N Engl J Med 354 2006 422 423
9. L.J. Ozelius, G. Senthil, R. Saunders-Pullman, E. Ohmann, A. Deligtisch, and M. Tagliati et al. LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews N Engl J Med 354 2006 424 425
10. U. Kumari, and E.K. Tan LRRK2 in Parkinson's disease: genetic and clinical studies from patients FEBS J 276 2009 6455 6463
11. X.K. An, R. Peng, T. Li, J.M. Burgunder, Y. Wu, and W.J. Chen et al. LRRK2 Gly2385Arg variant is a risk factor of Parkinson's disease among Han-Chinese from mainland China Eur J Neurol 15 2008 301 305
12. M.J. Farrer, J.T. Stone, C.H. Lin, J.C. Dächsel, M.M. Hulihan, and K. Haugarvoll et al. Lrrk2 G2385R is an ancestral risk factor for Parkinson's disease in Asia Parkinsonism Relat Disord 13 2007 89 92
13. E.K. Tan, Y. Zhao, L. Skipper, M.G. Tan, A. Di Fonzo, and L. Sun et al. The LRRK2 Gly2385Arg variant is associated with Parkinson's disease: genetic and functional evidence Hum Genet 120 2007 857 863
14. M. Funayama, Y. Li, H. Tomiyama, H. Yoshino, Y. Imamichi, and M. Yamamoto et al. Leucine-rich repeat kinase 2 G2385R variant is a risk factor for Parkinson disease in Asian population NeuroReport 18 2007 273 275
15. C. Li, Z. Ting, X. Qin, W. Ying, B. Li, and L. Guo Qiang et al. The prevalence of LRRK2 Gly2385Arg variant in Chinese Han population with Parkinson's disease Mov Disord 22 2007 2439 2443
16. H.C. Fung, C.M. Chen, J. Hardy, A.B. Singleton, and Y.R. Wu A common genetic factor for Parkinson disease in ethnic Chinese population in Taiwan BMC Neurol 6 2006 47
17. A. Di Fonzo, Y.H. Wu-Chou, C.S. Lu, M. van Doeselaar, E.J. Simons, and C.F. Rohé et al. A common missense variant in the LRRK2 gene, Gly2385Arg, associated with Parkinson's disease risk in Taiwan Neurogenetics 7 2006 133 138
18. E.K. Tan, Y. Zhao, L. Tan, H.Q. Lim, J. Lee, and Y. Yuen et al. Analysis of LRRK2 Gly2385Arg genetic variant in non-Chinese Asians Mov Disord 22 2007 1816 1818
19. S. Biskup, J.C. Mueller, M. Sharma, P. Lichtner, A. Zimprich, and D. Berg et al. Common variants of LRRK2 are not associated with sporadic Parkinson's disease Ann Neurol 58 2005 905 908
20. C. Paisán-Ruíz, E.W. Evans, S. Jain, G. Xiromerisiou, J.R. Gibbs, and J. Eerola et al. Testing association between LRRK2 and Parkinson's disease and investigating linkage disequilibrium J Med Genet 43 2006 e9
21. A.J. Hughes, S.E. Daniel, L. Kilford, and A.J. Lees Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases J Neurol Neurosurg Psychiatry 55 1992 181 184
22. S. Shirasawa, H. Harada, K. Furugaki, T. Akamizu, N. Ishikawa, and K. Ito et al. SNPs in the promoter of a B cell-specific antisense transcript, SAS-ZFAT, determine susceptibility to autoimmune thyroid disease Hum Mol Genet 13 2004 2221 2231
23. K. Nakabayashi, G. Komaki, A. Tajima, T. Ando, M. Ishikawa, and J. Nomoto et al.Identification of novel candidate loci for anorexia nervosa at 1q41 and 11q22 in Japanese by a genome-wide association analysis with microsatellite markers J Hum Genet 54 2009 531 537
24. Tanaka K, Miyake Y, Fukushima W, Sasaki S, Kiyohara C, Tsuboi Y, et al. Active and passive smoking and risk of Parkinson's disease. Acta Neurol Scand in press, doi:10.1111/j.1600-0404.2010.01327.x.
25. T. Andersson, L. Alfredsson, H. Källberg, S. Zdravkovic, and A. Ahlbom Calculating measures of biological interaction Eur J Epidemiol 20 2005 575 579
26. I.F. Mata, W.J. Wedemeyer, M.J. Farrer, J.P. Taylor, and K.A. Gallo LRRK2 in Parkinson's disease: protein domains and functional insights Trends Neurosci 29 2006 286 293
27. M. Jaleel, R.J. Nichols, M. Deak, D.G. Campbell, F. Gillardon, and A. Knebel et al. LRRK2 phosphorylates moesin at threonine-558: characterization of how Parkinson's disease mutants affect kinase activity Biochem J 405 2007 307-7
28. A. Ahlbom, and L. Alfredsson Interaction: a word with two meanings creates confusion Eur J Epidemiol 20 2005 563 564
29. M. Quik Smoking, nicotine and Parkinson's disease Trends Neurosci 27 2004 561 568